Skip to main content

Nonallergic Rhinitis Market Size, Growth Analysis, Company Profiles, Latest Technology and Trends

 Nonallergic Rhinitis Market Share, Growth And Trends Analysis By Diagnosis (Physical Examination, Allergy Testing, And Imaging Test), By Treatment (Nasal Sprays, Nsaids), And By End User (Hospitals &, Clinics, Research Centers) - Global Forecast Till 2023

Market Highlights

Nonallergic rhinitis, also known as vasomotor rhinitis is a medical condition that refers to a set of symptoms that resemble nasal allergies and hayfever (allergic rhinitis) occurring without a known cause. Some of the symptoms of non-allergic rhinitis include Postnasal drip, Runny nose, Sneezing, and Stuffy nose among others. Some patients with nonallergic rhinitis may even develop allergies and asthma eventually, hence treating the condition well in time becomes essential.

Industry, Innovation & Related News

November 08, 2018 – AstraZeneca Plc. (the UK), a multinational pharmaceutical and biopharmaceutical company announced the sale of its rights for asthma drug Alvesco (ciclesonide), nasal sprays Omnaris, and Zetonna (ciclesonide) to Covis Pharma (Switzerland) for USD 350MN.

AstraZeneca mentioned that it was its strategic objectives to divest parts of its portfolio which will allow the company to allocate resources to develop innovative new medicines to address unmet patient needs. Alvesco, Omnaris, and Zetonna which are used for the treatment of nasal symptoms associated with seasonal allergic and allergic/non-allergic perennial rhinitis will continue to benefit patients.

According to the agreement, Covis Pharma, a leading global player in the marketing of medicines will also make conditional sales-related payments for the three over-the-counter (OTC) drugs of up to USD 21 MN over four years from 2019.

Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/5137

Although causes triggering the non-allergic rhinitis are unknown, environmental irritants are considered as common triggers of this condition. Treatment of nonallergic rhinitis depends on its severity, for instance; for mild cases, home treatment and avoiding triggers may be enough whereas, for some typically serious conditions, certain medications are referred such as nasal antihistamines, oral decongestants, and over-the-counter (OTC) drugs or prescription medications.

There are a number of novel treatments already available in the market, that along with the several ongoing research activities to discover breakthrough therapeutics and drugs to treat the conditions drive the growth of the non-allergic rhinitis market. Moreover, major factors such as the rising prevalence of nonallergic rhinitis along with the increasing demand for diagnosis and treatment of conditions are escalating the market on the global platform.

Acknowledging the heightened growth, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global nonallergic rhinitis market is expected to register approximately 5.3% CAGR, creating a significantly larger revenue pocket throughout the assessment period (2017 – 2023).

Additional factors propelling the market growth include increasing population, urbanization, and industrialization led by the improving economic conditions that are expanding access to the quality healthcare, increasing healthcare expenditure.  Furthermore, the burgeoning healthcare industry alongside the splendid research in the field of immunology boosts market growth.

On the other hand, factors such as the increasing competition among key players impede the market growth, acting as a barrier of new entrants. Nevertheless, factors such as the growing focus on the development of new medications and the increasing use of non-steroidal anti-inflammatory drugs (NSAIDs) are expected to support market growth throughout the review period.

Global Nonallergic Rhinitis Market   - Segmentations 

The MRFR analysis is segmented into four key dynamics for enhanced understanding.

By Diagnosis: Physical Examination, Allergy Testing, and Imaging Test among others.

By Treatment: Nasal Sprays and NSAIDs among others.

By End-user: Hospitals & Clinics and Research Centers among others.

By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.

Major Players:

Key players leading the global nonallergic rhinitis market include Novartis (U.S.), Boehringer Ingelheim GmbH (Germany), GlaxoSmithKline (U.K), Johnson & Johnson Consumer Inc. (U.S.), Perrigo Company plc (Ireland), Bayer (U.S.), and Sanofi (France) among others.

Access Report Details @  https://www.marketresearchfuture.com/reports/nonallergic-rhinitis-market-5137

The report for Global market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

TOC:

  1.  Report Prologue    

    2.    Market Introduction   


          2.1    Definition    

          2.2    Scope of the Study    

                2.2.1    Research Objective    

                2.2.2    Assumptions    

                2.2.3    Limitations    

    3.    Research Methodology

          3.1    Introduction

          3.2    Primary Research    

          3.3    Secondary research

          3.4    Market Size Estimation

    TOC…Continued

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/5137

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Popular posts from this blog

Thyroid Test Market Overview 2020 Global Share, Demand- Supply Consumption Analysis to 2023

Thyroid Test Market  in Healthcare organizations are operating in a dynamic set-up, wherein they are required to incorporate unprecedented advances in diagnostic and therapeutic procedures, every now and then. It has thus become an uphill task for organizations to reap benefits from the latest and upcoming information technologies and offer discerning managed care to patients. Top Market Driving Key Vendors of Global Thyroid Test Market are,  Key Players Abbott (US) Merck (Germany) Thermo Fisher (US) Danaher (US) Roche (Switzerland) Diasorin (Italy) Biomérieux (France) Diagnostic Automation/Cortez Diagnostics (US) Qualigen (US) Kronus (US) Autobio Diagnostics (China) The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detailed information and strategies of the key pl...

Current Research on Epilepsi Disease As Sunovion Epilepsy, Anticonvulsant Drugs And New Epilepsy Drugs

Epilepsy  Synopsis Epilepsy is a major neurological disorder in which the brain activity becomes abnormal causing periods of unusual behavior and sensations. It  is also known as  vanquix in Many regions.  The disorder is noticeable in young children and young adults. Moreover, brain injuries which can trigger post-traumatic epilepsy (PTE) and post-traumatic seizure (PTS) can fuel the demand in the epilepsy market. what is  epilepsi disease and  anticonvulsant drugs in 2019?  The Global Epilepsy Market is projected to touch a valuation of USD 9,509.2 million by 2023, exhibiting a CAGR of 8.20% over the forecast period (2018-2023). High prevalence of  anti epilepsy drugs  among the geriatric population and increase in cases of brain injuries caused by accidents are major factors driving market growth of  epilepsy medication. Free Sample Here   Developing economies in Africa offer a prime oppo...

surgical chips market by Applications in Healthcare due to Rising Number of Health Awareness

The surgical chips market is growing pervasively mainly due to the burgeoning healthcare sector. The market is booming and expected to gain prominence over the forecast period. Market Scenario prohibiting cost of these surgical chips, risks associated with the surgeries, and the skepticism toward technology are some of the factors impeding the growth of the market. However, recent developments in surgical chips such as high integration of advanced artificial intelligence (AI) technology along with the spreading awareness towards the advantages and usages of surgical chips for patient tracking, medical records management, and healthcare quality control are expected to support the growth of the surgical chips market throughout the review period. Avail Free Sample at  https://www.marketresearchfuture.com/sample_request/1310 These technological advancements are leading to widening the applications of these chips for various tasks that have been directed towards reducing the costs ...